, /PRNewswire/ -- The Maryland Stem Cell Research Commission ("the ") announces the release of Requests for Applications (RFAs) for the Maryland Stem Cell Research Fund's ( ) first funding cycle of fiscal year 2025 (FY25). RFAs for this initial cycle are for five grant programs: Manufacturing Assistance, Clinical, Validation, Commercialization, and Launch. All applications are due by .
Along with this announcement comes the news that the Commission is also extending grant funding to businesses outside of for the Commercialization grant program, provided the research activities are conducted within the State. The Clinical grant program is available to entities with at least one clinical site in . "This expansion aims to support the advancement of the field while promoting economic development in ," said , chair of the Commission.
Recently, the Commission launched new strategic initiatives under the Validation and Commercialization grant programs, aiming to foster deliberate collaboration between the private and public sectors. "Applicants who partner with a company or university to create a public-private partnership will be eligible for an additional above the maximum grant award. By providing additional funding to companies and academic institutions for collaboration, we aim to strengthen and sustain the innovative ecosystem in for stem cell research," stated , executive director of MSCRF.
"This initiative underscores MSCRF's steadfast commitment to accelerating the developm.
